194 related articles for article (PubMed ID: 29094256)
21. Cholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex.
London E; Wassif CA; Horvath A; Tatsi C; Angelousi A; Karageorgiadis AS; Porter FD; Stratakis CA
J Clin Endocrinol Metab; 2015 Oct; 100(10):3660-7. PubMed ID: 26204136
[TBL] [Abstract][Full Text] [Related]
22. Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?
Eller-Vainicher C; Morelli V; Salcuni AS; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Carnevale V; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A; Chiodini I
Eur J Endocrinol; 2010 Jan; 162(1):91-9. PubMed ID: 19797503
[TBL] [Abstract][Full Text] [Related]
23. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
24. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
[TBL] [Abstract][Full Text] [Related]
25. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
[TBL] [Abstract][Full Text] [Related]
26. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
27. [The localization diagnosis of patients with adrenocorticotropic hormone-dependent Cushing's syndrome in adolescence].
Chen S; Pan ZX; Lu L; Tong AL; Pan H; Zhu HJ; Yao Y; Feng M; Wang RZ; Lu ZL
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2674-2677. PubMed ID: 28910955
[No Abstract] [Full Text] [Related]
28. [A pedigree study of a patient with primary pigmented nodular adrenocortical disease and familial gene mutation].
Ran H; Ma X; Wang Q; Xie Z; Ding Y; Qin G
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):398-402. PubMed ID: 25146409
[TBL] [Abstract][Full Text] [Related]
29. Primary pigmented nodular adrenocortical disease: diagnosis and management.
Grant CS; Carney JA; Carpenter PC; van Heerden JA
Surgery; 1986 Dec; 100(6):1178-84. PubMed ID: 3787476
[TBL] [Abstract][Full Text] [Related]
30. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
Batista DL; Riar J; Keil M; Stratakis CA
Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
[TBL] [Abstract][Full Text] [Related]
32. A case of preclinical Cushing's syndrome associated with diurnal rhythms of ACTH and cortisol in blood: correlation with histological findings.
Ikarashi T; Kamoi K; Asakawa K; Tanaka M; Miyakoshi M; Komeyama T; Morishita H; Usuda H; Emura I; Sasano H
Endocr J; 2006 Oct; 53(5):609-13. PubMed ID: 16896266
[TBL] [Abstract][Full Text] [Related]
33. Adrenocorticotropic hormone (ACTH) independent Cushing's syndrome due to unilateral adrenocortical hyperplasia: two case reports.
Aouinati Y; Mjabber A; Haraj NE; Aziz SE; Chadli A
Pan Afr Med J; 2021; 38():367. PubMed ID: 34367446
[TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling.
Martins RG; Agrawal R; Berney DM; Reznek R; Matson M; Grossman AB; Druce MR
Endocr Pract; 2012; 18(6):e153-7. PubMed ID: 22982799
[TBL] [Abstract][Full Text] [Related]
35. Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review.
Yang WR; Liang XH; Qin YF; Yang HY; He SZ; Huang ZX; Liu YP; Luo ZJ
Arch Endocrinol Metab; 2023 Nov; 68():e220491. PubMed ID: 37988664
[TBL] [Abstract][Full Text] [Related]
36. Primary pigmented nodular adrenocortical disease with synaptophysin immunoreactivity in two thai children.
Patarakijvanich N; Kayasut K; Mitarnun W; Pathrapinyokul S; Ayudya SS
J Med Assoc Thai; 2007 Jun; 90(6):1208-13. PubMed ID: 17624220
[TBL] [Abstract][Full Text] [Related]
37. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a novel index for the differential diagnosis of corticotropin-dependent Cushing syndrome.
Ding L; Wang B; Chen T; Li P; Guo W; Fan Y; Fang F; Cui J; Dong Z; He Q; Liu M
Pituitary; 2021 Aug; 24(4):507-516. PubMed ID: 33502672
[TBL] [Abstract][Full Text] [Related]
39. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
40. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
